Previous close | 165.98 |
Open | 169.70 |
Bid | 0.00 x 1100 |
Ask | 0.00 x 1200 |
Day's range | 169.39 - 173.65 |
52-week range | 109.16 - 173.65 |
Volume | 13,972,747 |
Avg. volume | 7,730,140 |
Market cap | 448.795B |
Beta (5Y monthly) | 0.70 |
PE ratio (TTM) | 26.81 |
EPS (TTM) | 6.36 |
Earnings date | 20 Apr 2021 |
Forward dividend & yield | 4.04 (2.43%) |
Ex-dividend date | 22 Feb 2021 |
1y target est | 174.06 |
Johnson and Johnson expects vaccine data next week.
Intuitive Surgical is down more than 7% since the start of this year. Does this present a buying opportunity or is it the harbinger of more bad news?
Johnson & Johnson (NYSE: JNJ) delivered an encouraging set of quarterly results on Tuesday, which included a promising -- albeit limited -- update on its coronavirus vaccine candidate. For the sprawling company's fourth quarter of fiscal 2020, revenue came in at just under $22.